Qarzning balans qiymatiga nisbati: traconpharma.com (TCON)

TRACON (TCON) kompaniyasining korporativ logotipi

TRACON Pharmaceuticals patent nizolari bo'yicha kelishuvlar va testlarning monetizatsiyasiga tayanadi. Biznes muvaffaqiyati onkologik tadqiqotlar uchun bemorlarni jalb qilish sur'atlari va tartibga soluvchi organlarning tasdiqlashlariga asoslangan. Biroq, daromadli mahsulotlarning yo'qligi kompaniyani o'zining suyuq rezervlari hisobiga yashashga majbur qilmoqda. Balans kapitalida qarz ishtiroki foizi moliyaviy leverajni vizuallashtiradi va 0.00 ushbu baholash parametrini xarakterlaydi.

TRACON Pharmaceuticals, Inc (TCON): Qarzning sof aktivlarga nisbati 04.07.2022dan 04.08.2024gacha

TRACON Pharmaceuticals Inc. (TCON) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi TRACON Pharmaceuticals|TCON - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor bahosi TRACON Pharmaceuticals, Inc|TCON - Biznesning umumiy qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar TRACON Pharmaceuticals|TCON - Kompaniyaning buxgalteriya qiymati|Bozor kapitallashuvining balans qiymatiga nisbati traconpharma.com|TCON - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati TRACON Pharmaceuticals|TCON - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati TRACON|TCON - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati TRACON Pharmaceuticals, Inc
Kompaniyaning jamlanma tahliliyoti:TCON - TRACON Pharmaceuticals
TRACON tomonidan chiqariladigan mahsulotlar

Ushbu koeffitsiyent qarz mablag‘larining kapitalga nisbatini o‘lchab, moliyaviy leveraj darajasini va to‘lovga qobiliyatsizlik xavfini belgilaydi. Investorlar balans tuzilmasining tashqi zarbalarga chidamliligini baholash uchun ushbu metrikadan foydalanadilar. GURU.Markets platformasida moliyaviy qarzning kapitalning balans qiymatiga nisbatini tahlil qilish orqali resurslarni konservativ boshqarish tendentsiyalarini aniqlash mumkin. TRACON Pharmaceuticals (TCON) uchun sog‘liqni saqlash gigantlari orasidan hamkorlar izlashda qarz yuklamasining pastligi kritik ahamiyatga ega. Bu onkologik dori vositalari uchun qimmatga tushadigan klinik sinovlar davrida moliyaviy barqarorlikni ta’minlaydi.

TRACON Pharmaceuticals (TCON) raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|QGEN - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Ionis IONS|RGEN: Qarzning balans kapitaliga nisbati|Qarzning balans kapitallashuviga nisbati Avidity RNA|CRISPR (CRSP) - Qarzning sof aktivlarga nisbati|WGS (GeneDx Holdings Corp.) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar ultragenyx.com|Balans kapitallashuviga qarzlar BEAM (Beam Therapeutics)|Qarzning balans qiymatiga nisbati SRPT (Sarepta Therapeutics)|TWST: Qarzning balans kapitallashuviga nisbati|10x - Balans qiymatiga qarzlar|Intellia Therapeutics (NTLA) - Qarzning balans kapitallashuviga nisbati|stoketherapeutics.com (STOK) - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati BioLife Solutions BLFS|WVE (Wave Life Sciences Ltd) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Maze Tx MAZE|Qarzlarning balans kapitallashuviga nisbati Sionna Corp|Prime Medicine, Inc. (PRME) - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati tayshagtx.com (TSHA)|Balans kapitallashuviga qarzlar QURE (uniQure)|MeiraGTx Holdings - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regenxbio (RGNX)|SLDB: Qarzning sof aktivlarga nisbati|OCGN (Ocugen, Inc.) - Qarzning balans kapitallashuviga nisbati|pacb.com (PACB) - Qarzning balans qiymatiga nisbati|BNTC (Benitec Biopharma) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Design Therapeutics Inc|Balans kapitallashuviga qarzlar RCKT (Rocket Pharmaceuticals Inc)|Qarzning balans qiymatiga nisbati 4D Molecular Corp (FDMT)|LXEO: Balans kapitallashuviga qarzlar|KRRO - Balans qiymatiga qarzlar|Editas Medicine - Qarzning balans qiymatiga nisbati|Silence Therapeutics PLC (SLN) - Balans kapitallashuviga qarzlar|PRQR - Qarzning balans qiymatiga nisbati|Codexis (CDXS) - Qarzning balans kapitaliga nisbati|SGMO: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Nautilus Biotechnology Inc|Balans kapitallashuviga qarzlar MGX (Metagenomi)|Qarzning balans qiymatiga nisbati Precision BioSciences Inc. (DTIL)|Balans kapitallashuviga qarzlar GBIO (Generation Bio)|Boundless Bio Inc - Balans kapitallashuviga qarzlar|XCUR - Qarzning balans kapitallashuviga nisbati|IMNN: Qarzning balans kapitallashuviga nisbati|phiopharma.com - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Mustang Bio|TransCode Therapeutics Inc. (RNAZ) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Bionano|Balans kapitallashuviga qarzlar APDN (Applied DNA Sciences)|Qarzning balans qiymatiga nisbati BLUE (bluebirdbio.com)|IPA: Qarzning balans kapitallashuviga nisbati|Omega Therapeutics Inc - Balans qiymatiga qarzlar|Singular Genomics Systems Inc (OMIC) - Qarzning balans kapitallashuviga nisbati|RGLS - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar Syros Pharmaceuticals|TBIO (telesisbio.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Unity Biotechnology, Inc. (UBX)